These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1632581)

  • 1. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.
    Sato M
    Ann N Y Acad Sci; 1992 Jun; 654():160-70. PubMed ID: 1632581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
    Sato M; Numachi Y; Hamamura T
    Schizophr Bull; 1992; 18(1):115-22. PubMed ID: 1553491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    J Clin Psychopharmacol; 1997 Feb; 17(1):34-43. PubMed ID: 9004055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine psychosis: insights from the past.
    McKetin R
    Addiction; 2018 Aug; 113(8):1522-1527. PubMed ID: 29516555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
    Yui K; Ikemoto S; Ishiguro T; Goto K
    Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of psychosis by phenylpropanolamine.
    Goodhue A; Bartel RL; Smith NB
    Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia.
    Yui K; Ikemoto S; Goto K; Nishijima K; Yoshino T; Ishiguro T
    Pharmacopsychiatry; 2002 Mar; 35(2):62-71. PubMed ID: 11951147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report.
    Iwanami A; Sugiyama A; Kuroki N; Toda S; Kato N; Nakatani Y; Horita N; Kaneko T
    Acta Psychiatr Scand; 1994 Jun; 89(6):428-32. PubMed ID: 8085475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic schizophrenia-like states in methamphetamine psychosis.
    Tomiyama G
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):531-9. PubMed ID: 2074612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamata Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):165-74. PubMed ID: 10770454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
    Yui K; Ishiguro T; Goto K; Ikemoto S; Kamata Y
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(2):103-11. PubMed ID: 10369157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Drug Alcohol Depend; 2000 Feb; 58(1-2):67-75. PubMed ID: 10669056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Psychiatry Res; 1996 Jul; 63(2-3):93-107. PubMed ID: 8878306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical course of chronic methamphetamine psychoses].
    Fujimori H; Nakatani Y; Sakaguchi M
    Fortschr Neurol Psychiatr; 1989 Sep; 57(9):383-94. PubMed ID: 2793033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine-induced psychosis.
    Brady KT; Lydiard RB; Malcolm R; Ballenger JC
    J Clin Psychiatry; 1991 Dec; 52(12):509-12. PubMed ID: 1752853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Angrist B; Duncan GE; Sheitman BB; Lieberman JA; Bracha SH; Ali SF
    Mol Psychiatry; 1999 Nov; 4(6):512-23. PubMed ID: 10578232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.